Sentinel Insight
- State
- PENDING
- Impact
- HIGH
- Metric
- Federal NDA Resubmitted
Psychedelic Alpha
Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application
Analysis News News Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application 12 August 2026 Last week, we reported that Resilient Pharmaceuticals (formerly Lykos Therapeutics ) has resubmitted its MDMA for PTSD new drug application (NDA) to the
Get email alerts when mushroom laws change in your area.
Email AlertsMerchants: Add legal status to your store →
Verified vendor: MIT45 — 10% off with code
Shop official siteMUSHROOMBANSAffiliate relationships do not influence legislative reporting.